150 related articles for article (PubMed ID: 37944569)
21. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca
Karlsson JOG; Jynge P
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932
[TBL] [Abstract][Full Text] [Related]
22. Carboplatin-induced micronuclei formation in non-neuronal cells of rat foetal dorsal root ganglia cultured in vitro and comparison with another anticancer drug--cisplatin.
Jirsová K; Mandys V
Sb Lek; 1996; 97(3):331-42. PubMed ID: 9174376
[TBL] [Abstract][Full Text] [Related]
23. Analysis of cytotoxicities of platinum compounds.
Goodisman J; Hagrman D; Tacka KA; Souid AK
Cancer Chemother Pharmacol; 2006 Jan; 57(2):257-67. PubMed ID: 16028101
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of mutagenic activity of platinum complexes in somatic cells of Drosophila melanogaster.
Allgayer N; de Campos RA; Gonzalez LPF; Flores MDA; Dihl RR; Lehmann M
Food Chem Toxicol; 2019 Nov; 133():110782. PubMed ID: 31465821
[TBL] [Abstract][Full Text] [Related]
25. Antioxidant Supplementation in the Treatment of Neurotoxicity Induced by Platinum-Based Chemotherapeutics-A Review.
Stankovic JSK; Selakovic D; Mihailovic V; Rosic G
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092125
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of toxic effects of platinum-based antineoplastic drugs (cisplatin, carboplatin and oxaliplatin) on green alga Chlorella vulgaris.
Dehghanpour S; Pourzamani HR; Amin MM; Ebrahimpour K
Aquat Toxicol; 2020 Jun; 223():105495. PubMed ID: 32371336
[TBL] [Abstract][Full Text] [Related]
27. Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells.
Hung CC; Li FA; Liang SS; Wang LF; Lin IL; Chiu CC; Lee CH; Chen JY
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825798
[TBL] [Abstract][Full Text] [Related]
28. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel.
Rixe O; Ortuzar W; Alvarez M; Parker R; Reed E; Paull K; Fojo T
Biochem Pharmacol; 1996 Dec; 52(12):1855-65. PubMed ID: 8951344
[TBL] [Abstract][Full Text] [Related]
29. Platinum-based chemotherapy plus cetuximab in head and neck cancer.
Vermorken JB; Mesia R; Rivera F; Remenar E; Kawecki A; Rottey S; Erfan J; Zabolotnyy D; Kienzer HR; Cupissol D; Peyrade F; Benasso M; Vynnychenko I; De Raucourt D; Bokemeyer C; Schueler A; Amellal N; Hitt R
N Engl J Med; 2008 Sep; 359(11):1116-27. PubMed ID: 18784101
[TBL] [Abstract][Full Text] [Related]
30. Chemoselective Synthesis of Mannich Adducts from 1,4-Naphthoquinones and Profile as Autophagic Inducers in Oral Squamous Cell Carcinoma.
Borges AA; de Souza MP; da Fonseca ACC; Wermelinger GF; Ribeiro RCB; Amaral AAP; de Carvalho CJC; Abreu LS; de Queiroz LN; de Almeida ECP; Rabelo VW; Abreu PA; Pontes B; Ferreira VF; da Silva FC; Forezi LDSM; Robbs BK
Molecules; 2022 Dec; 28(1):. PubMed ID: 36615502
[TBL] [Abstract][Full Text] [Related]
31. Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines.
Kitada N; Takara K; Minegaki T; Itoh C; Tsujimoto M; Sakaeda T; Yokoyama T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):577-84. PubMed ID: 18030470
[TBL] [Abstract][Full Text] [Related]
32. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
Nakahara S; Takenaka Y; Ogawa K; Nishiike S; Yamamoto Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Yoshii T; Tomiyama Y; Inohara H
Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
[TBL] [Abstract][Full Text] [Related]
33. Cetuximab-Carboplatin-5-Fluorouracil Regimen in Elderly Patients with Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma: A French Retrospective Survey.
Burgy M; Barthélémy P; Lefevre F; Dupret-Bories A; Truntzer P; Korenbaum C; Flesch H; Bronner G; Borel C
Oncology; 2017; 93(1):11-17. PubMed ID: 28423384
[TBL] [Abstract][Full Text] [Related]
34. Overview of the efficacy of cetuximab in recurrent and/or metastatic squamous cell carcinoma of the head and neck in patients who previously failed platinum-based therapies.
Vermorken JB; Herbst RS; Leon X; Amellal N; Baselga J
Cancer; 2008 Jun; 112(12):2710-9. PubMed ID: 18481809
[TBL] [Abstract][Full Text] [Related]
35. East-west fusion-necrosis and apoptosis acting in concert by demethylcantharidin-integrated platinum complexes.
Pang SK; So WK; Ho YP; Au-Yeung CF
Anticancer Agents Med Chem; 2014 Jun; 14(5):756-61. PubMed ID: 24476313
[TBL] [Abstract][Full Text] [Related]
36. In vitro effects of platinum compounds on renal cellular respiration in mice.
Almarzooqi SS; Alfazari AS; Abdul-Kader HM; Saraswathiamma D; Albawardi AS; Souid AK
Int J Clin Exp Pathol; 2015; 8(1):81-95. PubMed ID: 25755695
[TBL] [Abstract][Full Text] [Related]
37. Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer.
Sun L; Candelieri-Surette D; Anglin-Foote T; Lynch JA; Maxwell KN; D'Avella C; Singh A; Aakhus E; Cohen RB; Brody RM
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1022-1028. PubMed ID: 36136306
[TBL] [Abstract][Full Text] [Related]
38. Detecting acute neurotoxicity during platinum chemotherapy by neurophysiological assessment of motor nerve hyperexcitability.
Hill A; Bergin P; Hanning F; Thompson P; Findlay M; Damianovich D; McKeage MJ
BMC Cancer; 2010 Aug; 10():451. PubMed ID: 20731872
[TBL] [Abstract][Full Text] [Related]
39. Ototoxicity among cisplatin, carboplatin, and oxaliplatin in zebrafish model.
Li KH; Zhao YY; Cheng HL; Yang JJ; Chien CY
Environ Toxicol; 2024 Apr; ():. PubMed ID: 38661261
[TBL] [Abstract][Full Text] [Related]
40. A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress.
Bruno PM; Liu Y; Park GY; Murai J; Koch CE; Eisen TJ; Pritchard JR; Pommier Y; Lippard SJ; Hemann MT
Nat Med; 2017 Apr; 23(4):461-471. PubMed ID: 28263311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
